Nitric oxide synthases and diabetic cardiomyopathy

Nitric Oxide - Biology and Chemistry

Volumn 43, Issue , 2014, Pages 29-34

  Khanna, Sanskriti ^a   Singh, Gurinder Bir ^a   Khullar, Madhu ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Diabetic cardiomyopathy; Epigenetic; NOS

Indexed keywords

NITRIC OXIDE SYNTHASE;

CARDIOVASCULAR DISEASE; DIABETIC CARDIOMYOPATHY; DNA MODIFICATION; ENDOTHELIAL DYSFUNCTION; EPIGENETICS; FEMALE; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; DIABETIC CARDIOMYOPATHIES; ENZYMOLOGY; HEART MUSCLE; METABOLISM;

DIABETIC CARDIOMYOPATHIES; HUMANS; MYOCARDIUM; NITRIC OXIDE SYNTHASE;

EID: 84913590927     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2014.08.004     Document Type: Review

References (60)

1. S.A. Hayat, B. Patel, R.S. Khattar, and R.A. Malik Diabetic cardiomyopathy: mechanisms, diagnosis and treatment Clin. Sci 107 6 2004 539 557
2. J.G. Duncan Mitochondrial dysfunction in diabetic cardiomyopathy Biochim. Biophys. Acta 1813 7 2011 1351 1359
3. T. Miki, S. Yuda, H. Kouzu, and T. Miura Diabetic cardiomyopathy: pathophysiology and clinical features Heart Fail. Rev 18 2 2013 149 166
4. P. Geraldes, and G.L. King Activation of protein kinase C isoforms and its impact on diabetic complications Circ. Res 106 8 2010 1319 1331
5. L.A. Barouch, R.W. Harrison, M.W. Skaf, G.O. Rosas, T.P. Cappola, and Z.A. Kobeissi Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms Nature 416 6878 2002 337 339
6. I.N. Mungrue, and D.S. Bredt nNOS at a glance: implications for brain and brawn J. Cell Sci 117 Pt 13 2004 2627 2629
7. C.E. Sears, S.M. Bryant, E.A. Ashley, C.A. Lygate, S. Rakovic, and H.L. Wallis Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling Circ. Res 92 5 2003 e52 e59
8. O. Gealekman, Z. Abassi, I. Rubinstein, J. Winaver, and O. Binah Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure Circulation 105 2 2002 236 243
9. J.L. Balligand, and P.J. Cannon Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences Arterioscler. Thromb. Vasc. Biol 17 10 1997 1846 1858
10. S. Moncada, R.M. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol. Rev 43 2 1991 109 142
11. K.M. Naseem The role of nitric oxide in cardiovascular diseases Mol. Aspects Med 26 1-2 2005 33 65
12. S. Janssens, P. Pokreisz, L. Schoonjans, M. Pellens, P. Vermeersch, and M. Tjwa Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction Circ. Res 94 9 2004 1256 1262
13. M. Scherrer-Crosbie, R. Ullrich, K.D. Bloch, H. Nakajima, B. Nasseri, and H.T. Aretz Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice Circulation 104 11 2001 1286 1291
14. F. Ichinose, K.D. Bloch, J.C. Wu, R. Hataishi, H.T. Aretz, and M.H. Picard Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency Am. J. Physiol. Heart Circ. Physiol 286 3 2004 H1070 H1075
15. R.M. Saraiva, K.M. Minhas, S.V.Y. Raju, L.A. Barouch, E. Pitz, and K.H. Schuleri Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium Circulation 112 22 2005 3415 3422
16. D. Dawson, C.A. Lygate, M.-H. Zhang, K. Hulbert, S. Neubauer, and B. Casadei nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction Circulation 112 24 2005 3729 3737
17. P. Krenek, J. Kmecova, D. Kucerova, Z. Bajuszova, P. Musil, and A. Gazova Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function Eur. J. Heart Fail 11 2 2009 140 146
18. J. Heger, A. Gödecke, U. Flögel, M.W. Merx, A. Molojavyi, and W.N. Kühn-Velten Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction Circ. Res 90 1 2002 93 99
19. F. Sam, D.B. Sawyer, Z. Xie, D.L. Chang, S. Ngoy, and D.A. Brenner Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction Circ. Res 89 4 2001 351 356
20. Y.-H. Liu, O.A. Carretero, O.H. Cingolani, T.-D. Liao, Y. Sun, and J. Xu Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction Am. J. Physiol. Heart Circ. Physiol 289 6 2005 H2616 H2623
21. P. Zhang, X. Xu, X. Hu, E.D. van Deel, G. Zhu, and Y. Chen Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure Circ. Res 100 7 2007 1089 1098
22. K. Shibata, H. Shimokawa, N. Yanagihara, Y. Otsuji, and M. Tsutsui Nitric oxide synthases and heart failure - lessons from genetically manipulated mice J. UOEH 35 2 2013 147 158
23. S.D. Prabhu Nitric oxide protects against pathological ventricular remodeling: reconsideration of the role of NO in the failing heart Circ. Res 94 9 2004 1155 1157
24. I.N. Mungrue, M. Husain, and D.J. Stewart The role of NOS in heart failure: lessons from murine genetic models Heart Fail. Rev 7 4 2002 407 422
25. R.M. Saraiva, and J.M. Hare Nitric oxide signaling in the cardiovascular system: implications for heart failure Curr. Opin. Cardiol 21 3 2006 221 228
26. M. Felaco, A. Grilli, M.A. De Lutiis, A. Patruno, N. Libertini, and A.A. Taccardi Endothelial nitric oxide synthase (eNOS) expression and localization in healthy and diabetic rat hearts Ann. Clin. Lab. Sci 31 2 2001 179 186
27. U. Hink, H. Li, H. Mollnau, M. Oelze, E. Matheis, and M. Hartmann Mechanisms underlying endothelial dysfunction in diabetes mellitus Circ. Res 88 2 2001 E14 E22
28. R.C. Sampaio, J.E. Tanus-Santos, S.E.S.F.C. Melo, S. Hyslop, K.G. Franchini, and I.M. Luca Hypertension plus diabetes mimics the cardiomyopathy induced by nitric oxide inhibition in rats Chest 122 4 2002 1412 1420
29. J. MacMicking, Q.W. Xie, and C. Nathan Nitric oxide and macrophage function Annu. Rev. Immunol 15 1997 323 350
30. A.L. Bardell, and K.M. MacLeod Evidence for inducible nitric-oxide synthase expression and activity in vascular smooth muscle of streptozotocin-diabetic rats J. Pharmacol. Exp. Ther 296 2 2001 252 259
31. P.R. Nagareddy, Z. Xia, J.H. McNeill, and K.M. MacLeod Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes Am. J. Physiol. Heart Circ. Physiol 289 5 2005 H2144 H2152
32. H. Farhangkhoee, Z.A. Khan, S. Chen, and S. Chakrabarti Differential effects of curcumin on vasoactive factors in the diabetic rat heart Nutr. Metab 3 2006 27
33. S. Jesmin, S. Zaedi, S. Maeda, I. Yamaguchi, K. Goto, and T. Miyauchi Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats Exp. Biol. Med. (Maywood) 231 6 2006 925 931
34. M.J. Crespo, J. Zalacaín, D.C. Dunbar, N. Cruz, and L. Arocho Cardiac oxidative stress is elevated at the onset of dilated cardiomyopathy in streptozotocin-diabetic rats J. Cardiovasc. Pharmacol. Ther 13 1 2008 64 71
35. J. Cao, C. Vecoli, D. Neglia, B. Tavazzi, G. Lazzarino, and M. Novelli Cobalt-protoporphyrin improves heart function by blunting oxidative stress and restoring NO synthase equilibrium in an animal model of experimental diabetes Front. Physiol 3 2012 160
36. P. Puthanveetil, D. Zhang, Y. Wang, F. Wang, A. Wan, and A. Abrahani Diabetes triggers a PARP1 mediated death pathway in the heart through participation of FoxO1 J. Mol. Cell. Cardiol 53 5 2012 677 686
37. A. Pautz, J. Art, S. Hahn, S. Nowag, C. Voss, and H. Kleinert Regulation of the expression of inducible nitric oxide synthase Nitric Oxide 23 2 2010 75 93
38. H. Jo, H. Otani, F. Jo, T. Shimazu, T. Okazaki, and K. Yoshioka Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice Clin. Exp. Pharmacol. Physiol 38 8 2011 485 493
39. J. Ren, J. Duan, D.P. Thomas, X. Yang, N. Sreejayan, and J.R. Sowers IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction Am. J. Physiol. Regul. Integr. Comp. Physiol 294 3 2008 R793 R802
40. N.D. Roe, D.P. Thomas, and J. Ren Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction Diabetes Obes. Metab 13 5 2011 465 473
41. R.M. Saraiva, K.M. Minhas, M. Zheng, E. Pitz, A. Treuer, and D. Gonzalez Reduced neuronal nitric oxide synthase expression contributes to cardiac oxidative stress and nitroso-redox imbalance in ob/ob mice Nitric Oxide 16 3 2007 331 338
42. J. Amour, X. Loyer, M. Le Guen, N. Mabrouk, J.-S. David, and E. Camors Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide Anesthesiology 107 3 2007 452 460
43. P.R. Nagareddy, H. Soliman, G. Lin, P.S. Rajput, U. Kumar, and J.H. McNeill Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats Diabetes 58 10 2009 2355 2364
44. H. Soliman, A. Gador, Y.-H. Lu, G. Lin, G. Bankar, and K.M. MacLeod Diabetes-induced increased oxidative stress in cardiomyocytes is sustained by a positive feedback loop involving Rho kinase and PKC 2 Am. J. Physiol. Heart Circ. Physiol 303 8 2012 H989 H1000
45. S. Lei, H. Li, J. Xu, Y. Liu, X. Gao, and J. Wang Hyperglycemia-induced protein kinase C β2 activation induces diastolic cardiac dysfunction in diabetic rats by impairing caveolin-3 expression and Akt/eNOS signaling Diabetes 62 7 2013 2318 2328
46. P. Cubas, C. Vincent, and E. Coen An epigenetic mutation responsible for natural variation in floral symmetry Nature 401 6749 1999 157 161
47. G.B. Singh, R. Sharma, and M. Khullar Epigenetics and diabetic cardiomyopathy Diabetes Res. Clin. Pract 94 1 2011 14 21
48. M. Asrih, and S. Steffens Emerging role of epigenetics and miRNA in diabetic cardiomyopathy Cardiovasc. Pathol 22 2 2013 117 125
49. Y. Chan, J.E. Fish, C. D'Abreo, S. Lin, G.B. Robb, and A.-M. Teichert The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation J. Biol. Chem 279 33 2004 35087 35100
50. J.E. Fish, C.C. Matouk, A. Rachlis, S. Lin, S.C. Tai, and C. D'Abreo The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code J. Biol. Chem 280 26 2005 24824 24838
51. C.V. Breton, C. Park, K. Siegmund, W.J. Gauderman, L. Whitfield-Maxwell, and H.N. Hodis NOS1 methylation and carotid artery intima-media thickness in children Circ. Cardiovasc. Genet 7 2 2014 116 122
52. X. Rao, J. Zhong, S. Zhang, Y. Zhang, Q. Yu, and P. Yang Loss of methyl-CpG-binding domain protein 2 enhances endothelial angiogenesis and protects mice against hind-limb ischemic injury Circulation 123 25 2011 2964 2974
53. A. Rodriguez, S. Griffiths-Jones, J.L. Ashurst, and A. Bradley Identification of mammalian microRNA host genes and transcription units Genome Res 14 10A 2004 1902 1910
54. B. Feng, S. Chen, B. George, Q. Feng, and S. Chakrabarti miR133a regulates cardiomyocyte hypertrophy in diabetes Diabetes Metab. Res. Rev 26 1 2010 40 49
55. S. Chen, P. Puthanveetil, B. Feng, S.J. Matkovich, G.W. Dorn 2nd, and S. Chakrabarti Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes J. Cell. Mol. Med 18 3 2014 415 421
56. B. Liu, J. Hewinson, H. Xu, F. Montero, C.R. Sunico, and F. Portillo NOS antagonism using viral vectors as an experimental strategy: implications for in vivo studies of cardiovascular control and peripheral neuropathies Meth. Mol. Biol 704 2011 197 223
57. M. Weber, M.B. Baker, J.P. Moore, and C.D. Searles miR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity Biochem. Biophys. Res. Commun 393 4 2010 643 648
58. Z. Guo, L. Shao, L. Zheng, Q. Du, P. Li, and B. John miRNA-939 regulates human inducible nitric oxide synthase posttranscriptional gene expression in human hepatocytes Proc. Natl Acad. Sci. U.S.A. 109 15 2012 5826 5831
59. M. Meloni, M. Marchetti, K. Garner, B. Littlejohns, G. Sala-Newby, and N. Xenophontos Local inhibition of microRNA-24 improves reparative angiogenesis and left ventricle remodeling and function in mice with myocardial infarction Mol. Ther 21 7 2013 1390 1402
60. F. Patella, E. Leucci, M. Evangelista, B. Parker, J. Wen, and A. Mercatanti MiR-492 impairs the angiogenic potential of endothelial cells J. Cell. Mol. Med 17 8 2013 1006 1015